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Abstract. Serum immunoreactive erythropoietin (siEPO) was 
determined in cord serum from neonates (n = 97, gestational 
age 36-43 weeks), in healthy children from birth to adoles- 
cence (n = 260) and in children with haematological (n = 30), 
renal (n = 10) and congenital heart diseases (n = 70). In healthy 
children siEPO levels decreased after birth (geometric mean 
cord siEPO 35.6mU/ml with 95% range of 17-56mU/ml in 
eutrophic, nondistressed fetuses) and reached lowest values 
during the first 2 months (geometric mean siEPO l l .5mU/  
ml). Thereafter siEPO levels increased slightly and were con- 
stant between 2months and adolescence. The geometric mean 
siEPO for healthy children after birth was 18.8mU/ml with 
95% range of 7-47 mU/ml. These estimates were not signifi- 
cantly different from normal adult values. In newborns with 
fetal distress (n = 15) cord siEPO was significantly elevated 
(geometric mean 63.0 mU/ml; P < 0.001). In children with 
haematological disease, siEPO and Hb concentration were in- 
versely correlated (log siEPO (mU/ml)= 4.1 - 0.20 x Hb 
(g/dl); r=-0 .62 ;  P<0.0005). This relationship was signifi- 
cantly different in children with chronic renal failure (log 
siEPO (mU/ml) = 0.67 + 0.035 • Hb (g/dl); r = 0.50; P = 0.1). 
In children with heart disease the geometric mean siEPO was 
19.2mU/ml with 95% range 8-65 mU/ml for cyanotic (SaO2 
< 94%) and 17.7 mU/ml with 95% range of 12-36 mU/ml for 
acyanotic patients. In this group siEPO values were inversely 
correlated to the arterial oxygen content (log siEPO (mU/ml) 
= 1.61 - 2.04 x oxygen content (1/t); r = -0.28; P < 0.02). 
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Introduction 
Erythropoietin (EPO) is considered the primary regulator of 
red cell formation [20]. The development of sensitive radio- 
immunoassays for the estimation of EPO allows the routine 
measurement of the hormone in biological fluids. In order to 
determine whether disorders of erythropoiesis are related to 
inappropriate EPO production, normal values and their alter- 
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ations in different diseases must be established. In adults nor- 
mal serum values and the physiological relationship of serum 
EPO levels to Hb concentration are well known [2, 5, 7, 8, 10, 
16-18, 24]. Less information is available, however, on EPO 
levels in childhood. Only recently have values from healthy 
children between birth and 16 years been reported [12]. In 
previous tudies in children with conditions uch as prematur- 
ity, cardiopulmonary, haematological nd renal disorders [1, 
3, 4, 11, 15, 19, 22], estimates were generally related to adult 
levels because values in normal children were not available. It 
was the intention of this study to determine the age and sex 
distribution of serum EPO concentrations in healthy children 
between birth and adolescence. Furthermore, we studied the 
relationship of serum EPO levels to arterial oxygen content in 
children with haematological, renal and congenital heart dis- 
eases and compared these parameters with those of healthy in- 
fants. 
Subjects and methods 
The study was carried out according to the principles of the 
Declaration of Helsinki. 
Newborns 
Cord serum samples were obtained immediately after birth 
from 97 consecutively delivered neonates (gestational ge 36- 
43 weeks). Eight of these newborns uffered from intrauterine 
hypothrophy. Fifteen newborns had signs of fetal distress, 
when defined as i min Apgar score below 7 or umbilical artery 
pH below 7.2. 
Healthy children 
Serum samples of 260 healthy children (age 1 day-15 years) 
and 14 adolescents (age 16-20 years) were available for analy- 
sis. All children and adolescents participated in a growth study 
with the informed consent of the parents and the ethical com- 
mittee of the University of Ulm, Federal Republic of Ger- 
many. 
Adult controls 
For comparison, serum immunoreactive erythropoietin (siEPO) 
levels were also determined in 84 adults (age range 21-87 years) 
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with their informed consent. These were either members of 
laboratory staff or medical in-patients for elective ye surgery. 
None suffered from a haematological, cardiopulmonary or
renal disease, as confirmed by case history and routine labora- 
tory tests. 
Children with haematological disorders 
SiEPO was measured in 30 children (age 2-16 years) with 
anaemias of various aetiologies. In 15 patients anaemia was 
due to an aregenerative bone marrow, including severe aplas- 
tic anaemia, pure red cell aplasia and Blackfan Diamond dis- 
ease. The other 15 children suffered from 13-thalassaemia and 
were periodically transfused every 3 to 4 weeks. All children 
had normal renal function. None had received transfusions for 
at least 2 weeks prior to blood sampling for determination of
serum EPO. Arterial oxygen content was calculated from Hb 
concentrations (see below) assuming 97% SaO2. 
Children with renal failure 
Ten patients with renal failure were investigated (age 2-16 
years). One had acute renal failure due to haemolytic uraemic 
syndrome, and nine suffered from chronic renal failure of var- 
ious aetiologies (two cases each with nephronophthisis, 
obstructive uropathy and glomerulonephritis, and one case 
each with congenital renal hypoplasia, Alport syndrome and 
interstitial nephritis). Glomerular filtration rate ranged from 7 
to 55 ml/min with a mean of 26 ml/min. None of these children 
received recombinant EPO or had undergone renal transplan- 
tation. 
Children with congenital heart disease 
Seventy patients with various forms of congenital heart dis- 
ease were studied (age 3 days-16 years). These included 32 
patients with single malformations (atrial or ventricular septal 
defect, persistent ductus arteriosus, pulmonary or aortic valve 
stenosis, hypoplastic left ventricle and transposition or great 
arteries) and 38 patients with complex vitia. All patients had 
normal serum creatinine values. Cyanosis was considered pre- 
sent if SaO2 was less than 94% and absent if - 94%. Arterial 
oxygen content was calculated as follows: SaO2 • Hb (g/ 
dL) • 1.34. 
Radioirnmunoassay for EPO 
SiEPO was determined by radioimmunoassay exactly as de- 
scribed [6]. In brief, 100 gl samples plus 20 gl of 30% bovine 
serum albumin were incubated with 100 gl rabbit antiserum 
raised against recombinant human EPO for 24h. 100 btl of 
tracer (8 x 10-11mol/1 125I EPO; Amersham International, 
Amersham, UK) were then added and after an additional in- 
cubation period of 24 h free and bound ligand were separated 
using a second antibody technique. As a standard we used the 
2nd International Reference Preparation of human urinary 
EPO (WHO). 
Data evaluation and statistics 
Since serum EPO levels were approximately log-normally dis- 
tributed (see results), EPO levels were log-transformed for 
plotting and calculations and geometric means were calculated 
for groups of observations. Unpaired Student -test was used 
for comparison of groups and analysis of variance to deter- 
mine significance levels of linear regressions. A P-value 
< 0.05 was considered to be significant. 
Results 
Healthy children 
SiEPO concentrations of 260 healthy children (age 1 day-15 
years) ranged from 5 to 95 mU/ml. The geometric mean was 
18.8mU/ml and the 95% range 7-47mU/ml. Only two chil- 
dren had siEPO levels higher than 54 mU/ml and were there- 
fore analysed separately. The frequency distribution of siEPO 
for the remaining 258 children (131 boys and 127 girls) is 
shown in Fig. 1. After log-transformation, siEPO values in 
boys and girls were approximately normally distributed. 
There was no sex difference for the whole group (geometric 
mean 18.6 mU/ml for boys and 18.8 mU/ml for girls) or at any 
age. 
Figure 2 shows the distribution of siEPO values in relation 
to age for (i) the above 258 healthy children, (ii) 75 nondis- 
tressed, eutrophic newborns (cord siEPO), (iii) healthy ado- 
lescents (n = 14; age range 16-20 years; geometric mean 21.4 
mU/ml; 95% range from 13 to 36 mU/ml) and (iv) normal adults 
(n = 84; geometric mean 17.9mU/ml; 95% range from 11-31 
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Fig. 2. Estimates of siEPO in healthy 
children in relation to age. For compari- 
son values of healthy adolescents and 
healthy adults are included. Values are 
geometric mean, interquartile range and 
total range 
Table 1. Serum EPO values in children between 1 and 40 days after 400 
birth 
Age (days) Sex siEPO (mU/ml) Haematocrit (%) 
1 M 12 0.67 
1 M 13 0.70 
i M 7 0.65 lO0 
1 F 12 0.72 
1 M 53 0.71 g 
I M 10 0.65 0 II. 
2 F 12 0.66 ua 
.1= 
2 M 7 0.62 E 
2 M 12 0.62 
10 M 6 0.49 
15 M 5 0.43 
20 F 6 0.29 
10 20 F 53 0.44 
20 M 17 0.48 
30 M 5 0.40 
8 
30 M 18 0.39 
30 M 23 0.46 
40 M 5 0.45 
mU/ml). Through childhood, from age 2 months to 15 years, 
siEPO was essentially constant and the same as found in adults. 
In younger infants estimates of siEPO were different. In cord 
blood of healthy newborns we found a geometric mean of 
35.6 mU/ml (95% range 17-56 mU/ml), which was significant- 
ly higher than in children after birth (P < 0.001). In children 
aged 1 day to 2 months, geometric mean siEPO was 11.5 mU/ 
ml (95% range 5-53 mU/ml; n = 18) and significantly lower 
than in older children (P < 0.05). Individual values for children 
in this group are given in Table 1. 
In two girls (10 and 11 years old, respectively), who were 
primarily included in the group of healthy children, siEPO 
levels were higher than in the other children (79 and 95 mU/ 
ml, respectively). No obvious reason for the increased levels 
was apparent from clinical and laboratory data. 
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Fig. 3. Relationship of cord siEPO levels to gestational ge in 97 new- 
borns. Values fit the linear regression curve: log siEPO (mU/ 
ml) = -0.8 + 0.06 • gest. age (weeks); r = 0.33, P < 0.002 
Hypotrophic newborns and newborns with signs 
of fetal distress 
In hypotrophic newborns median gestational age was 37 
weeks (range 36-38weeks) and median birth weight was 
2150 g (range 1720-2350 g). Geometric mean cord siEPO in 
these children was 29.9 mU/ml (95% range 17-56 mU/ml) and 
not significantly different from eutrophic neonates with nor- 
mal umbilical artery pH and Apgar score (P > 0.20). 
In newborns with signs of fetal distress, defined as either 
i min Apgar score below 7 or umbilical artery pH below 7.2, 
median 1 min Apgar score was 7 (range 3-9) and median 
umbilical artery pH 7.18 (range 7.13-7.27). Geometric mean 
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Fig. 4. Relationship of siEPO levels to Hb concentrations i  children 
with bone marrow insufficiency (filled symbols) and thalassaemia 
(open symbols). Values fit the linear regression curve: log siEPO 
(mU/ml) = 4.1 - 0.20 x Hb (g/dl); r = -0.62; P< 0.0005. Horizontal 
bar shows mean siEPO and interquartile range of healthy children, 
age 0-15 years 
cord siEPO in this group was 63.0mU/ml (95% range 17-331 
mU/ml; P<0.001 vs eutrophic, nondistressed newborns). 
Furthermore, when values from all newborns were analysed 
together, a slight but statistically significant inverse correla- 
tion was found between umbilical artery pH and cord siEPO 
(log siEPO (mU/ml) = 7.9 - 0.87 • pH; r = -0.21, P < 0.05). 
In addition, in the whole group of neanates cord siEPO in- 
creased with gestational age (log siEPO (mU/ml)= 
-0.8 + 0.06 • gest. age (weeks); r = 0.33, P< 0.002) (Fig. 3). 
Anaemic children 
A relationship of siEPO to Hb concentrations was discovered 
in blood samples obtained from anaemic hildren with bone 
marrow aplasia nd thalassaemia (Fig. 4). The children of this 
group were aged between 2 and 16 years (mean 8.2 years). 
SiEPO ranged between 14 and 6000 mU/ml, and Hb between 
4 and 13 g/dl. SiEPO and Hb concentration were inversely 
correlated and showed a negative linear egression when plot- 
ted on a semilogarithmic scale (log siEPO (mU/ml)= 
4 .1 -0 .20•  Hb (g/dl); r=-0 .62 ;  P<0.0005) (Fig. 3). This 
relationship of siEPO to Hb was significantly different in a 
group of anaemic hildren suffering from renal disease (log 
siEPO (mU/ml) = 0.67 + 0.035 • Hb (g/dl); r = 0.50; P = 0.1) 
(Fig. 5). This group consisted of 10 uraemic hildren aged be- 
tween 2 and 16 years. SiEPO values remained low even during 
severe anaemia. 
The relationship of siEPO to Hb was also altered in heal- 
thy children during the 1st trimenon (Fig. 5). It appears that 
the values in healthy children during the 1st trimenon are at 
the lower limit of those obtained in children with haematolog- 
ical diseases. 
200 
100 
E 
50 
E 
0 
n 
LU 
E 
| 
10 
iiiiiiiiii 
i 
I i I I I l I l l I l I 
5 6 7 8 9 10 11 12 13 14 15 16 
hemoglobin (g/all) 
Fig. 5. Relationship of siEPO levels to Hb concentrations i  ten chil- 
dren with renal disease (open circles) and in healthy children during 
age 0.5-3 months (closed circles). The dotted iagonal bar indicates 
the 95% confidence interval for values found in anaemic children, the 
horizontal bars show mean siEPO and interquartile range of healthy 
children, age 0-15 years (dotted) and healthy adults (hatched) (o= indi- 
cates an EPO value below 5 mU/ml) 
10000 
E 1000 9 9 | 
o 9 9 \ : - \  
100 9 ! 
[] \ "  9 [ ] \  [] 
5 
I I i t I 
0.05  0.1 0 .15  0 .2  0 .25  
oxygen content  (I/I) 
~g. 6. Relationship of siEPO levels to arterial blood oxygen content 
in children with congenital heart disease (open symbols) and anaemias 
(closed symbols). Bars show geometric mean siEPO and interquartile 
range for healthy children (dotted) and adults (hatched) 
Children with heart disease 
We determined siEPO in 70 children with congenital heart 
disease, aged between 3 days and 16 years (mean 3.5 years). 
Fifty of them were cyanotic (SaOz<94%). The geometric 
mean of siEPO was 19.2 mU/ml and the 95% range from 8 to 
65 mU/ml for the cyanotic hildren. For the acyanotic hil- 
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dren, the geometric mean was 17.7 mU/ml and the 95% range 
from 12 to 36 mU/ml. The difference between cyanotic and 
acyanotic hildren was not significant. SiEPO was neither cor- 
related with Hb nor with SaO2. An inverse correlation, how- 
ever, was observed between siEPO and arterial oxygen con- 
tent (log siEPO (mU/ml) = 1.61 -2.04 x oxygen content (1/1); 
r = -0.28; P< 0.02). 
It is evident from Fig. 6 that the data obtained from chil- 
dren with heart disease and those obtained from healthy chil- 
dren and children with haematological disease fit a consistent 
relationship of siEPO to arterial oxygen content. 
Discussion 
Our observation that siEPO concentrations in healthy chil- 
dren between 2 months of age and adolescence were not sig- 
nificantly different from those of healthy adults confirms pre- 
vious results by Hellebostad et al. [12]. We also found no sex 
differences nor significant changes of siEPO during puberty 
(Figs. 1, 2). The latter finding could indicate that the expan- 
sion or red cell mass during accelerated body growth is not 
primarily triggered by EPO. It supports the concept hat the 
adaptation of red cell mass to body mass during growth is con- 
trolled by other factors uch as insulin-like growth factor I [14]. 
SiEPO values in cord blood were significantly higher than 
serum levels during childhood and showed considerable varia- 
tion (Fig. 2). The magnitude of cord serum values in our study 
is comparable to that reported by Thomas et al. [21]. These 
results extend previous investigations, that demonstrated ryth- 
ropoietic activity in cord blood and 1st day urine, but not 
during the following weeks by employing less sensitive bioas- 
says for EPO [9]. In addition to Thomas and coworkers, who 
demonstrated an increase in EPO levels from 19 weeks gesta- 
tion until term [21], we found a significant increase also during 
late gestation (Fig. 3). The importance of EPO for the regula- 
tion of fetal erythropoiesis is further supported by previous 
studies, demonstrating increased EPO levels in the presence 
of placental insufficiency and fetal hypoxia [9, 21, 23]. Also in 
the present investigation EPO levels in children with signs of 
fetal distress were elevated and cord blood EPO was inversely 
correlated with umbilical artery pH, indicating that fetal EPO 
production can respond to hypoxia. 
During the 1st trimenon, when an anaemia develops, 
rather low siEPO values were found. The same observation 
was made by Hellebostad et al. [12] and may indicate that the 
physiological feedback loop between oxygen delivery and 
EPO production- well established for adults [8] - is less sensi- 
tive during the 1st trimenon. The idea is supported by our ob- 
servation that the relationship of siEPO to Hb during the first 
3 months was in the lower range of that obtained from older 
children with haematological diseases (Fig. 5). This also com- 
plies with the observation made by Brown et al. [3, 4] that in 
premature infants there is a decreased response of EPO pro- 
duction to available oxygen. 
The inverse relationship of siEPO to Hb, which we found 
in children with haematological disorders, agrees with the re- 
sults obtained by McGonigle et al. [15] and was almost identi- 
cal with that of adult patients [8, 17]. This finding suggests that 
the feedback loop of EPO production as known from adults is 
already established uring the first years of life. Due to the 
relatively small number of haematological patients in our 
study it was not possible to clearly distinguish whether the re- 
lationship of siEPO to Hb is different during ineffective and 
aregenerative erythropoiesis a suggested by two other studies 
[15, 19]. As in adults the relationship of siEPO to Hb was sig- 
nificantly altered in children with renal failure and their 
anaemia was accompanied by inappropriate low levels of siEPO 
(Fig. 4). Inappropriate low EPO levels in uraemic children 
have also been observed in another study [1]. Both studies 
thus indicate indirectly that the kidneys are the physiological 
production site of EPO already during childhood. 
The observation that siEPO levels in children with heart 
disease are not significantly different from those in healthy 
children are in accordance with previous reports [11, 22]. On 
first glance it may be surprising that there is no difference in 
siEPO between cyanotic and acyanotic hildren and that, in 
contrast to anaemic hildren, there is no correlation of siEPO 
to Hb concentrations. However, EPO production is in general 
inversely related to renal oxygen supply [13]. In states of un- 
physiological oxygen saturation therefore siEPO should be in- 
versely related to the arterial oxygen content rather than to 
the Hb concentration. In fact, such a relationship was seen in 
this and two other studies [11, 22]. Moreover, we found that a 
consistent relationship of siEPO to arterial oxygen content re- 
sulted when the data from healthy children and children with 
haematological nd heart diseases were combined (Fig. 6). 
Thus the lack of abnormal siEPO values during heart disease 
appears to result from a very fine tuning of the feedback loop 
of EPO production. 
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